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journal homepage: www.e-t jo.comEditorialInfectious keratitis after excimer laser corneal surgeryThe excimer laser has been evolving for more than two de-
cades. Because of its submicron precision, submicron collateral
damage, and minimal thermal energy effect, the excimer laser
was commonly used for corneal surgeries, including laser in
situ keratomileusis (LASIK), surface ablation procedures (PRK,
LASEK and epi-LASIK), and phototherapeutic keratectomy
(PTK). Among the reported complications, infectious keratitis,
although rare, is the most devastating. The causes of infectious
keratitis are bacterial, fungal, and parasitic.1e3 It is difﬁcult to
estimate the incidence of infectious keratitis following excimer
laser corneal surgery because of its low incidence. A major re-
view carried out by Chang et al4 showed a wide variation in
the published rates of post-LASIK infectious keratitis (0e1.5%).
The American Society of Cataract and Refractive Surgery (ASCRS)
reported 116 cases of post-LASIK microbial keratitis out of an
estimated 338,550 procedures,5 representing an infection rate
of 0.034%. Llovet et al6 performed a study by reviewing
204,586 eyes of 107,613 patients routinely followed over a 3-
month period and found an incidence of infectious keratitis of
0.035%. Several large case series demonstrated that microbial
keratitis after surface ablation is also a rare event, with an inci-
dence of 0.02% in two large case series; two cases from 10,452
PRK procedures in one series,7 and ﬁve eyes from 25,337 PRK
procedures in the other.8
In this issue, Ide et al9 report the ﬁrst multicenter survey on in-
fectious keratitis following excimer laser surgery in Japan. The LA-
SIK Safety Network (LSN) Committee sent questionnaires to 28 LSN
member hospitals to assess the total number of laser corneal sur-
geries, infection cases (including suspicious cases), and postopera-
tive follow-up incidence during a 3-year period. Responses were
obtained from 27 of the 28 institutes (96.4%). One PTK infection
case was reported in 22,415 excimer laser surgery cases, equating
to an incidence of 0.004%. The follow-up incidences were 94.14%
(67.2e100%), 80.11% (41.0e96.1%), 57.95% (11.5e93.0%), and
46.64% (4.7e93.0%) at 1 month, 3 months, 6 months, and 12
months of follow up, respectively. They concluded that the lowhttp://dx.doi.org/10.1016/j.tjo.2014.07.001
2211-5056/Copyright © 2014, The Ophthalmologic Society of Taiwan. Published by Elsevincidence of infection may be due to increased awareness and
improved sterile techniques.
Studies showed that risk factors may include a history of corneal
surgery, blepharitis, dry eye, epithelial defect, excessive manipula-
tion or contamination during surgery, delayed healing of the
corneal epithelium postoperatively, and use of topical
corticosteroids.4,6,10,11
Infectious keratitis after LASIK has been categorized into infec-
tions occurring within 1 week (early onset) and after 1 week (late
onset) of surgery. The organisms seen in early-onset infectious
keratitis are common bacterial pathogens, such as Staphylococcus
and Streptococcus species. Gram-negative organisms are rare. The
organisms seen in late-onset infectious keratitis are usually oppor-
tunistic, such as fungi, Nocardia, and atypical mycobacteria.4 It is
important to note that many cases of atypical mycobacterial LASIK
infections have occurred in clusters.12 Also, atypical mycobacterial
infection may become less common as the femtosecond laser is
increasingly used to create the lamellar ﬂap, because mycobacterial
infection has been associated with the contamination of steamers
used to clean microkeratomes. In an unpublished ASCRS survey
presented in 2008, the most common organism identiﬁed inmicro-
bial keratitis after LASIK was methicillin-resistant Staphylococcus
aureus (MRSA), and the incidence of atypical mycobacteriawas rare.
The treatment paradigm from the ASCRS White Paper recom-
mends lifting the ﬂap, and scraping and culturing suspicious cases
with appropriate culture media. At the time of culture, the inﬁltrate
should be scraped to perform a stain to rule out unusual pathogens,
such as Nocardia, atypical mycobacteria, and fungi.13 In cases in
which cultures are negative and the infection continues to worsen,
a corneal biopsy or polymerase chain reaction should be contem-
plated.14 For the treatment of rapid-onset and delayed-onset infec-
tious keratitis, the recommendation is to elevate the ﬂap and
culture. Irrigation of the ﬂap interface with an appropriate antibi-
otic solution (fortiﬁed vancomycin 50 mg/mL for rapid-onset kera-
titis and fortiﬁed amikacin 35 mg/mL for delayed-onset keratitis)
may be helpful. For rapid-onset keratitis a fourth-generation topical
ﬂuoroquinolone is recommended, given in a loading dose every 5
minutes for three doses, and then every 30 minutes, alternating
with fortiﬁed cefazolin 50 mg/mL every 30 minutes. If the patient
is exposed to a hospital environment, vancomycin 50 mg/mL
should be substituted for cefazolin. In addition, the use of oral
doxycycline, 100 mg twice a day, is advocated to inhibit collagenase
production and also discontinuation of corticosteroids. For delayed-
onset keratitis, which is commonly caused by atypical mycobacte-
ria, Nocardia, and fungi, therapy using amikacin 35 mg/mL every
30 minutes is recommended, alternating with a fourth-
generation ﬂuoroquinolone every 30 minutes, starting oral doxycy-
cline 100 mg twice a day, and discontinuing corticosteroids.13ier Taiwan LLC. All rights reserved.
Editorial / Taiwan Journal of Ophthalmology 4 (2014) 101e102102Infectious keratitis after laser corneal surgery is a rare complica-
tion. A high index of suspicion is pivotal for rapid management
because misdiagnosis at initial presentation may result in signiﬁ-
cant vision loss. Early lifting of the ﬂap to obtain culture and irriga-
tion of the interface with an antibiotic is also strongly
recommended. Empirical therapy should be discouraged because
most pathogens are opportunistic and do not respond to conven-
tional therapy. Continued study and presentation of case series
from multiple centers is necessary to provide clinically relevant in-
formation on the incidence, presentation, cause, and management
of infectious keratitis following laser corneal surgery.References
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